Oxilio announces start of its first clinical trial with OXL001
Oxilio has commenced first human subject dosing of OXL001. The product leverages the Quotient Sciences Translational Pharmaceutics® platform for drug development.
Emplicure AB Announce Completion of Phase I PK study for EMPLI03 with Quotient Sciences
Emplicure AB reported dosing in the first Phase I pharmacokinetic study for EMPLI03, intended for the treatment of moderate to severe pain. The program is supported by Quotient Sciences Translational Pharmaceutics® platform.
Oxilio and Quotient Sciences Announce Regulatory Approval for Oxilio’s OXL001 Development Program
Oxilio and Quotient Sciences announced an update on the development of Oxilio’s OXL001 product, which uses Quotient Sciences’ Translational Pharmaceutics® platform.
Ensysce Biosciences and Quotient Sciences Announce a Partnership on the Development and Clinical Testing of Ensysce’s PF614-MPAR
Partnership further expedites Ensysce’s development pipeline of PF614-MPAR, a novel opioid combination product for the potential treatment of chronic pain that is designed to prevent both abuse and overdose.
South Rampart Pharma Announces Patient Enrollment and Dosing Underway in Phase 1 Study Evaluating Novel Non-Opioid Approach to Pain with Lead Program, SRP-3D (DA)
SRP-3D (DA) has demonstrated a compelling safety profile over currently available pain medications Potential to address the significant unmet need for new, safe, effective, and non-opioid pain medications Development program funded by the National Institutes of Health (NIH) through a Small Business Technology Transfer (STTR) Fast Track Grant Topline results expected Q3 2022
Clinical Trials Arena Interview with Stuart McDougall, VP of Bioanalytical Services on bioanalytical and pharmacokinetics (PK) strategies
Quotient's VP of Bioanalytical Services, Stuart McDougall was featured in an interview with Clinical Trials Area discussing the Bioanalytical and Pharmacokinetics (PK) strategies at Quotient, and how we reduce risk and delay within the drug development process.